Top Markets
Coin of the day
Celadon Pharmaceuticals Plc Celadon Pharmaceuticals Plc

Celadon Pharmaceuticals Plc

CEL
Rangering i aksjer #40708
Celadon Pharmaceuticals Plc functions as a drug development company,... Celadon Pharmaceuticals Plc functions as a drug development company, concentrating on the discovery, production, and distribution of cannabinoid compounds for certified medical uses. The firm's primary activity involves the indoor, hydroponic cultivation of THC cannabis, which is then incorporated into medicinal products targeting chronic pain. Furthermore, Celadon intends to broaden its research into cannabinoids, exploring their therapeutic applications not only for persistent pain but also for conditions such as autism and multiple sclerosis. Established in 2018, the company maintains its headquarters in London, United Kingdom.
Aksjekurs
$0.00179028
Sist synkronisert: 2025-07-28
Markedsverdi
$94.61K
Endring (1 dag)
-0.54%
Endring (1 år)
0.00%
Land
GB
Handel Celadon Pharmaceuticals Plc (CEL)

Kategori

P/S-forhold for Celadon Pharmaceuticals Plc (CEL)
P/S-forhold per 2026 TTM: 0
Ifølge Celadon Pharmaceuticals Plc sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Celadon Pharmaceuticals Plc fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter